Page 2 - Anuron Kumar News Today

2 Min Read BENGALURU (Reuters) - Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. FILE PHOTO: Johnson & Johnsons coronavirus disease (COVID-19) vaccines are seen at Northwell Healths South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton/File Photo The U.S. drugs and healthcare giant’s vaccine is currently approved for use in the Unit...

2 Min Read BENGALURU (Reuters) - Indian shares fell over 1% on Wednesday, weighed down by a combination of increasing domestic COVID-19 cases, investors locking in gains and rising U.S. bond yields. A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, February 26, 2016. REUTERS/Shailesh Andrade/Files The blue chip NSE Nifty 50 index closed 1.27% lower at 14,721.30, while the benchmark S&P BSE Sensex fell 1.12% to end at 49,801.62. Both indexes have now pos...

2 Min Read BENGALURU (Reuters) - Indian shares fell over 1% on Wednesday, weighed down by a combination of increasing domestic COVID-19 cases, investors locking in gains and rising U.S. bond yields. A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, February 26, 2016. REUTERS/Shailesh Andrade/Files The blue chip NSE Nifty 50 index closed 1.27% lower at 14,721.30, while the benchmark S&P BSE Sensex fell 1.12% to end at 49,801.62. Both indexes have now pos...

3 Min Read BENGALURU, March 15 (Reuters) - Indian shares fell 1% on Monday, dragged down by financials, after February retail inflation surged to a three-month high, while a jump in COVID-19 cases also weighed on sentiment. By 0513 GMT, the blue-chip NSE Nifty 50 index declined 1.02% to 14,877.55, while the benchmark S&P BSE Sensex fell 1.05% to 50,259.50. A combination of rising COVID-19 cases, a jump in core inflation and a fall in industrial output weighed on market sentiment, according to A...

Heavyweight financial stocks boosted Indian shares to near one-month highs on Friday and put them on track for their second week of gains, while IDBI Bank surged after the country's central bank removed certain restrictions on the lender.

2 Min Read BENGALURU (Reuters) - Indian shares gave up early gains to end sharply lower on Friday, as high-flying financial stocks sold off on the back of a broader rise in bond yields in the U.S. and Europe. A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, February 26, 2016. REUTERS/Shailesh Andrade/Files The blue-chip NSE Nifty 50 index fell 0.95% to close at 15,030.95, while the benchmark S&P BSE Sensex shed 0.95% to end at 50,792.08. Despite today�...

2 Min Read BENGALURU (Reuters) - Indian shares rose on Tuesday as gains in high-flying financials eclipsed losses in energy stocks fuelled by a report that oil-marketing companies had been told by the government to not revise fuel prices for now. A broker trades on his computer terminal at a stock brokerage firm in Mumbai, India, January 20, 2016. REUTERS/Shailesh Andrade/Files By 0505 GMT, the blue-chip NSE Nifty 50 index climbed 0.71% to 15,061.90 and the benchmark S&P BSE Sensex gained 0.73%...

Indian shares ended flat on Monday, as losses in top non-banking finance company HDFC countered gains in information technology and energy stocks, while top gold financing company Muthoot Finance fell after the death of its chairman.

Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture Plc said on Wednesday they would cover COVID-19 vaccination costs for their employees in India, as the country expands its massive vaccination drive. India's vaccination campaign ramped up on Monday, with people above the age of 60, and individuals 45 or older suffering from certain medical conditions, now eligible for shots. Vaccines administered at government health facilities will still be...

By Anuron Kumar Mitra BENGALURU (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vacci...